Innovative device called Buzzy applies high-frequency vibration sensation and cold to soothe sting of shots
Search results for: pediatric
Blue Ribbon Panel on Academic Rheumatology Publishes Final Report
Report offers recommendations to address critical issues with training, practice, and research
ACR/ARHP Annual Meeting 2012: Federal Act Aims to Make New Biologic Drugs Available to Rheumatology Patients at a Lower Cost
The Biologics Price Competition and Innovation Act of 2009 would spur the development of products intended to be biosimilar to approved therapies
ACR/ARHP Annual Meeting 2012: Children Experience Pain Differently from Adults
Experts say children in pain from rheumatic diseases or other causes may have more discomfort because they can’t downregulate the pain as effectively as adults
The ACR Releases Top 5 Things as Part of Choosing Wisely Campaign
On February 21, the ACR–along with 16 other national medical societies–released its list of Five Things Patients and Physicians Should Question in Rheumatology.
Tackle Tricky Lung Complications in Connective Tissue Disease
Guidance for diagnosing and treating interstitial lung disease complications
Rheumatologists Harness the Power of Social Media to Reach Patients
Connecting online via Facebook chats has enabled rheumatologists at Nemours to educate patients and their families
The ARHP Honors Health Professionals for their Contributions to Rheumatology
The ARHP recognized individuals for their work in advancing rheumatology research, education, and patient care at the organizations’ annual meeting in Washington, D.C. last November
ACR/ARHP Annual Meeting 2012: Rheumatologists Take Proactive Approach in Talking with Teen Patients about Risky Behavior
With teenaged juvenile arthritis patients, it’s important for rheumatologists to engage in conversations about how drugs, tobacco, alcohol, and sex will affect them
Aggressive Treatment of Inflammation Prevents Vision Loss in Patients with JIA-related Uveitis
A new study confirms that the use of immunosuppressive drugs is associated with a reduced risk of vision loss in patients with juvenile idiopathic arthritis-related uveitis.
- « Previous Page
- 1
- …
- 85
- 86
- 87
- 88
- 89
- …
- 109
- Next Page »